Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business

Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenue

Gland Pharma has entered into a strategic Manufacturing and Supply Agreement (MSA) with a leading global pharmaceutical company to undertake technology transfer, manufacturing and supply of sterile injectable products for global markets, the company said on Sunday.

The agreement covers 55 SKUs to be manufactured across three Gland Pharma sites, with scope for additional products to be added. Once the portfolio is fully commercialised, the agreement is expected to have an annualised revenue potential of approximately $90 million-$100 million.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.